TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
NEO

NeoGenomics Inc

Healthcare · Diagnostics & Research

19.90$ +5.0% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for NeoGenomics Inc (NEO): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/27/2026.

Next report 10/27/2026
Last report 07/28/2026
Earnings surprise by quarter (%)
Q3 23 · 75.0 % 23 Q4 23 · 200.0 % 23 Q1 24 · 60.0 % 24 Q2 24 · 1,404.4 % 24 Q3 24 · -1,494.0 % 24 Q4 24 · 39.9 % 24 Q1 25 · -1,935.0 % 25 Q2 25 · 50.0 % 25 Q3 25 · 50.0 % 25 Q4 25 · 50.0 % 25 Q1 26 · -12.3 % 26 Q2 26 · 83.3 % 26

EPS estimate beaten

Full history 42 of 71 quarters (59%)
Last 16 quarters 13 of 16 quarters (81%)

Earnings Call Transcripts

Search all transcripts →

  • 04/28/2026 Earnings Call Q1 2026 Open →
  • 02/17/2026 Earnings Call Q4 2025 Open →
  • 10/28/2025 Earnings Call Q3 2025 Open →
  • 07/29/2025 Earnings Call Q2 2025 Open →
  • 04/29/2025 Earnings Call Q1 2025 Open →
  • 02/18/2025 Earnings Call Q4 2024 Open →
  • 11/05/2024 Earnings Call Q3 2024 Open →
  • 07/29/2024 Earnings Call Q2 2024 Open →
  • 04/30/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/11/2026 NEOGENOMICS INC (NEO): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗
  • 07/28/2026 NEOGENOMICS INC (NEO): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/20/2026 NEOGENOMICS INC (NEO): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?